Unlike current invasive pharmacodynamic assays which measure Raf-1 depletion and HSP70 induction (O'Dwyer et al, 1999; Clarke et al, 2000), the measurement by (methyl-11C)choline does not require the biopsy sampling of tumours which can be problematic. The gene discussed is RAF1; the disease is neoplasm.